Stryker Management

Management Kriterienprüfungen 3/4

Stryker's CEO ist Kevin Lobo , ernannt in Oct 2012, hat eine Amtszeit von 11.67 Jahren. Die jährliche Gesamtvergütung beträgt $20.77M , bestehend aus 6.7% Gehalt und 93.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.026% der Aktien des Unternehmens, im Wert von $34.68M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.8 Jahre bzw. 6.1 Jahre.

Wichtige Informationen

Kevin Lobo

Geschäftsführender

US$20.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	6.7%
Amtszeit als Geschäftsführer	11.9yrs
Eigentum des Geschäftsführers	0.03%
Durchschnittliche Amtszeit des Managements	6yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	6.3yrs

Jüngste Management Updates

Recent updates

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Sep 18

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Sep 01

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Jun 17

Stryker: Good Prospects

Jun 14

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

May 24

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Kevin Lobo im Vergleich zu den Einnahmen von Stryker verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Jun 30 2024	n/a	n/a	US$3b
Mar 31 2024	n/a	n/a	US$3b
Dec 31 2023	US$21m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$19m	US$1m	US$2b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$16m	US$1m	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$13m	US$1m	US$2b
Sep 30 2020	n/a	n/a	US$2b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	US$15m	US$1m	US$2b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$14m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$1b
Dec 31 2017	US$14m	US$1m	US$1b

Vergütung im Vergleich zum Markt: KevinDie Gesamtvergütung ($USD20.77M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD13.52M).

Entschädigung vs. Einkommen: KevinDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Kevin Lobo (59 yo)

11.9yrs

Amtszeit

US$20,767,847

Vergütung

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kevin Lobo	Chairman	11.9yrs	US$20.77m	0.026% $ 36.4m
Glenn Boehnlein	VP & CFO	8.4yrs	US$6.84m	0.0012% $ 1.6m
Viju Menon	Group President of Global Quality & Operations	6.4yrs	US$4.47m	0.0024% $ 3.3m
J. Pierce	Group President of MedSurg & Neurotechnology	6.1yrs	US$6.49m	0.015% $ 20.8m
Spencer Stiles	Group President of Orthopaedics & Spine	6.1yrs	US$6.49m	0.014% $ 18.8m
William Berry	VP & Chief Accounting Officer	3.1yrs	keine Daten	0.00078% $ 1.1m
Robert Cohen	CTO and VP of Global R&D - Joint Replacement	no data	keine Daten	keine Daten
Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	6yrs	keine Daten	keine Daten
Jason Beach	Vice President of Finance & Investor Relations	2.2yrs	keine Daten	keine Daten
Robert Fletcher	VP & Chief Legal Officer	5.4yrs	US$2.24m	0.0024% $ 3.4m
Dana McMahon	VP & Chief Compliance Officer	no data	keine Daten	keine Daten
Yin Becker	VP of Communications	5.8yrs	keine Daten	0.0082% $ 11.3m

6.0yrs

Durchschnittliche Betriebszugehörigkeit

57yo

Durchschnittliches Alter

Erfahrenes Management: SYKDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.8 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kevin Lobo	Chairman	11.9yrs	US$20.77m	0.026% $ 36.4m
Lisa Skeete Tatum	Independent Director	4.3yrs	US$319.25k	0.00085% $ 1.2m
Howard Cox	Director Emeritus	6.3yrs	US$38.86k	keine Daten
John Brown	Chairman Emeritus	no data	US$286.99k	5.26% $ 7.2b
Ronda Stryker	Independent Director	40.7yrs	US$319.25k	4.83% $ 6.7b
Mary Brainerd	Independent Director	7.1yrs	US$334.25k	0.0015% $ 2.1m
Allan Golston	Independent Director	13.7yrs	US$334.25k	0.0039% $ 5.4m
Sherilyn S. McCoy	Lead Independent Director	6.3yrs	US$359.25k	0.00022% $ 302.9k
Rajeev Suri	Independent Director	6.3yrs	US$319.25k	0.0014% $ 1.9m
Giovanni Caforio	Independent Director	3.8yrs	US$319.25k	0.00067% $ 922.6k
Andrew Silvernail	Independent Director	10.8yrs	US$339.25k	0.0015% $ 2.0m
Rachel Ruggeri	Independent Director	less than a year	keine Daten	0.000010% $ 13.8k

6.3yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: SYKDie Vorstandsmitglieder gelten als erfahren (6.1 Jahre durchschnittliche Amtszeit).

Stryker Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Independent Director notifies of intention to sell stock

VP & CFO recently sold US$6.7m worth of stock

VP & CFO exercised options and sold US$3.7m worth of stock

VP & CFO recently sold US$3.3m worth of stock

VP & Chief Accounting Officer notifies of intention to sell stock

Independent Director recently sold US$100m worth of stock

Recent updates

Upcoming dividend of US$0.80 per share

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Independent Director notifies of intention to sell stock

Stryker Announces Launch of Pangea Plating System

Stryker: Wait For A Better Entry Point Post-Q2 Results

VP & CFO recently sold US$6.7m worth of stock

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

VP & CFO exercised options and sold US$3.7m worth of stock

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors

Stryker: Mako Shoulder And Spine Launches Are On The Way

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of US$0.80 per share at 1.0% yield

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

VP & CFO exercised options and sold US$1.6m worth of stock